Benign tumors can be removed or destroyed through a range of methods, from traditional surgery to needle-based heat or cold treatments to focused beams of radiation or sound waves, and sometimes they can be shrunk with medication alone. The right approach depends on where the tumor is, how large it has grown, what symptoms it causes, and whether there is any concern about future changes. In many cases, the most appropriate treatment is no treatment at all.
When You Can Safely Leave a Benign Tumor Alone
The word “tumor” sounds alarming, but it simply means an abnormal mass of tissue. When that mass is benign, it is not cancerous, does not invade surrounding structures in the way cancers do, and usually grows slowly if it grows at all. Many benign tumors are discovered incidentally on imaging ordered for something else, and a large share of them never need treatment.
Watchful waiting, sometimes called active surveillance, involves periodic imaging or physical exams to confirm a benign tumor is staying the same size and not causing new problems. This is a reasonable strategy for small lipomas under the skin, many liver hemangiomas, certain ovarian cysts, and a range of other growths. One analysis of the cost implications of managing small kidney masses found that lifetime costs for active surveillance were roughly a third lower than the costs of immediate surgical treatment, making it a financially sensible option when the suspicion for malignancy is low.1The American Journal of Managed Care. Cost of Care for Malignant and Benign Renal Masses
The decision to treat a benign tumor usually hinges on symptoms. A benign brain tumor pressing on a nerve, a fibroid causing heavy bleeding, a large lipoma creating visible deformity, or a growth that causes chronic pain all warrant intervention. So does any mass with features that make it difficult to confidently rule out malignancy on imaging alone. For example, CT scans alone have limited ability to reliably distinguish small benign kidney lesions from malignant ones, which sometimes pushes the decision toward biopsy or removal even when cancer is unlikely.2PubMed. Characterization of small solid renal lesions: can benign and malignant tumors be differentiated with CT? Ultrasound elasticity imaging has improved the ability to tell benign from malignant breast lesions and can help avoid unnecessary biopsies of truly benign growths.3Journal of Medical Imaging and Health Informatics. Application of Elasticity Imaging Techniques Based on Ultrasound in Breast Tumor Activity, Blood Supply, and Benign and Malignant Tumor Diagnosis
Surgical Removal
Surgery remains the most definitive way to get rid of a benign tumor. The entire growth is physically taken out, which means there is tissue available for a pathologist to examine and confirm it truly is benign. For superficial lumps like lipomas or salivary gland tumors, this often means a relatively straightforward outpatient procedure. A study comparing two surgical techniques for benign tumors of the submandibular gland found no recurrences with either approach during follow-up, underscoring how effective complete excision is for accessible growths.4PubMed. Extracapsular dissection versus total excision for benign submandibular gland tumors
For tumors inside the abdomen or chest, minimally invasive approaches like laparoscopic or robotic surgery allow surgeons to work through small incisions using camera-guided instruments. A cohort study that included both laparoscopic and robot-assisted liver resections reported zero mortality and a complication rate of about 17 percent across a mixed group of patients with benign and malignant liver lesions.5Journal of Robotic Surgery. Conventional laparoscopic and robot-assisted laparoscopic liver resection for benign and malignant pathologies: a cohort study For benign disease specifically, the risk profile tends to be more favorable since the surgery is often less extensive than what cancer requires.
The trade-offs of surgery are the ones you would expect: general anesthesia, recovery time, potential for scarring, and the small but real risk of surgical complications like infection or bleeding. For a benign tumor that is not causing symptoms, those trade-offs can outweigh the benefits, which is why watchful waiting is sometimes preferred.
Thermal Ablation
If surgery feels like using a scalpel to carve out the problem, thermal ablation is more like cooking it in place. A thin needle or probe is inserted into the tumor, usually guided by ultrasound or CT imaging, and the tissue is destroyed with heat. The dead tissue gradually shrinks and is absorbed by the body over weeks to months.
The two main heat-based techniques are radiofrequency ablation and microwave ablation. Radiofrequency ablation uses electrical current to generate heat, while microwave ablation works at higher frequencies, allowing for faster treatment and the ability to treat larger areas in a single session.6PubMed Central. Advancements in microwave ablation for tumor treatment and future directions Both are used extensively for benign thyroid nodules, a common reason people seek treatment for a non-cancerous growth. A randomized trial comparing the two techniques for predominantly solid benign thyroid nodules found that microwave ablation was comparable to radiofrequency ablation, with both achieving similar volume reduction over two years and no significant difference in how often the treatment fully resolved the problem.7PubMed. Microwave versus Radiofrequency Ablation in Treating Predominantly Solid Benign Thyroid Nodules: A Randomized Controlled Trial
Thermal ablation is also used for benign liver tumors, kidney masses under observation, and bone tumors like osteoid osteomas. The appeal is that it avoids general anesthesia in many cases, requires no large incision, and lets patients recover much faster than surgery. The downsides are that there is no tissue specimen for a pathologist to examine afterward and the technique works best on smaller, well-defined tumors.
Cryoablation
Cryoablation flips the temperature script: instead of heat, it uses extreme cold delivered through a probe to freeze and destroy tumor cells. Ice crystals form inside the cells, and the resulting damage kills the tissue. One advantage of cryoablation is that the ice ball forming around the probe tip is visible in real time on imaging, giving the operator a clear picture of how much tissue is being treated.
Cryoablation has shown particular promise for soft-tissue tumors. An educational review found it effective for desmoid tumors, vascular malformations, and abdominal wall endometriosis, among others.8PubMed Central. Percutaneous cryoablation in soft tissue tumor management: an educational review It is also used for small kidney tumors and some bone lesions. The procedure is typically performed through the skin with local anesthesia and sedation, and recovery is generally quick. Temporary soreness and swelling at the treatment site are common, but serious complications are uncommon.
Medication That Shrinks Tumors
For a handful of benign tumor types, drugs can shrink or control the growth without any procedure at all. The best-known examples are hormone-driven tumors, particularly certain pituitary adenomas that overproduce specific hormones.
Prolactinomas, which are benign pituitary tumors that secrete too much prolactin, often respond dramatically to dopamine-stimulating medications. In one study of 30 patients with large prolactinomas treated with dopaminergic drugs, prolactin levels dropped in 28, and 20 of those also showed clear shrinkage of the tumor on imaging.9PubMed. Macroprolactinomas: CT evaluation of reduction of tumor size after medical treatment For these patients, medication is typically the first-line treatment, with surgery reserved for tumors that do not respond.
A similar principle applies to rare TSH-secreting pituitary tumors, where somatostatin analog drugs like octreotide can normalize hormone levels and produce rapid tumor shrinkage. In one case report, tumor size shrank dramatically within six weeks and the effect was sustained over two years of treatment.10PubMed. A rare case and a rapid tumor response to therapy: dramatic reduction in tumor size during octreotide treatment in a patient with TSH-secreting pituitary macroadenoma Uterine fibroids represent another category where medications, including GnRH agonists and newer oral options, can reduce fibroid size and symptom burden, though the tumors often regrow once the medication is stopped.
Medication-based approaches are limited to tumor types that have a known biological vulnerability a drug can target. Most benign tumors, like lipomas or many soft-tissue masses, have no effective drug therapy and require a procedural approach if treatment is needed.
Embolization
Embolization works by cutting off a tumor’s blood supply. A catheter is threaded through the blood vessels, usually from a small puncture in the groin, to the arteries feeding the tumor. Tiny particles, coils, or other agents are injected to block those vessels, starving the growth and causing it to shrink.
This approach is commonly used for uterine fibroids (called uterine artery embolization) and for certain liver hemangiomas. It works well for symptom relief and size reduction, but has limitations. Very large tumors with multiple feeding vessels can be difficult to fully embolize, and new blood vessels sometimes grow to resupply the tumor afterward.11PubMed Central. Long-term result of transcatheter arterial embolization for liver hemangioma For that reason, embolization may be a stepping stone before surgery or a standalone option mainly for patients who are not good surgical candidates.
Stereotactic Radiosurgery
Despite the word “surgery” in its name, stereotactic radiosurgery involves no cutting. It delivers highly focused beams of radiation to a tumor from multiple angles, concentrating the dose inside the target while sparing surrounding tissue. The technique is most associated with treating benign brain tumors, where traditional surgery carries higher risks due to the sensitivity of nearby structures.
Gamma Knife radiosurgery, one of the most widely used platforms, has a strong track record for meningiomas, which are the most common benign brain tumors. Long-term follow-up data show it to be safe and effective, and it is especially useful for tumors left behind after incomplete surgical removal or in locations where full excision would be risky.12PubMed Central. Long-Term Results of Gamma Knife Radiosurgery for Intracranial Meningioma
Vestibular schwannomas (sometimes called acoustic neuromas) are another common benign target. These grow on the nerve connecting the inner ear to the brain and can cause hearing loss, tinnitus, and balance problems. Stereotactic radiosurgery controls growth in the vast majority of cases, with progression-free survival rates of about 87 percent at five years and 81 percent at ten years in one long-term study.13PubMed. Stereotactic radiosurgery for vestibular schwannoma: early and long-term radiation-induced changes and tumor growth control The goal is usually to stop the tumor from growing rather than eliminate it entirely, and the mass often remains visible on imaging even when treatment is successful.
Focused Ultrasound
High-intensity focused ultrasound, or HIFU, uses sound waves concentrated at a precise point inside the body to heat and destroy tissue. No needle or incision is required. The procedure is typically performed under ultrasound or MRI guidance, making it one of the least invasive options available.14PubMed Central. High-Intensity Focused Ultrasound Surgery for Tumor Ablation: A Review of Current Applications It has been used for a variety of solid tumors including those in the liver, kidney, bone, prostate, and breast, as well as uterine fibroids and some soft-tissue sarcomas.15PubMed Central. An Introduction to High Intensity Focused Ultrasound: Systematic Review on Principles, Devices, and Clinical Applications
For benign breast lumps called fibroadenomas, a feasibility study of ultrasound-guided HIFU found the treated masses shrank by an average of about two-thirds at twelve months, with the lump no longer palpable in 80 percent of patients. Patient satisfaction was high and all adverse effects were mild and temporary, mostly limited to low-level pain during and shortly after the procedure.16PubMed. Treatment of Breast Fibroadenoma with Ultrasound-Guided High-Intensity Focused Ultrasound Ablation: A Feasibility Study For superficial vascular tumors like cherry angiomas and other small vascular growths on or near the skin surface, HIFU has produced clear cosmetic improvement with minimal scarring.17PubMed Central. Treatment of superficial benign vascular tumors by high intensity focused ultrasound: Observations in two illustrative cases
HIFU is still not available at every hospital, and treatment sessions can be lengthy for larger tumors because the focused beam treats a small volume at a time. But as systems improve and gain wider regulatory clearance, it is expanding into more clinical settings.
Laser Ablation in the Brain
MRI-guided laser interstitial thermal therapy, sometimes called MRg-LITT, is a newer minimally invasive technique designed mainly for targets inside the brain. A thin laser fiber is inserted through a small hole in the skull, and near-infrared light energy heats and destroys the tumor while real-time MRI displays temperature maps every few seconds. Clinicians can see exactly how much tissue has been damaged and adjust the energy delivery to avoid critical brain structures.18ILSC 2023: Proceedings of the International Laser Safety Conference. Magnetic resonance guided laser interstitial thermal therapy (MRg-LITT)
This technique is still relatively new compared to established options like Gamma Knife or open surgery, but it fills a niche for patients with tumors in difficult-to-reach locations or those who cannot tolerate a craniotomy. It requires only a small scalp incision and typically involves a shorter hospital stay than open brain surgery.
When a Benign Tumor Carries Cancer Risk
Most benign tumors stay benign. But a few types occupy a gray zone where the line between benign and precancerous is fuzzy, and that ambiguity sometimes pushes the decision toward treatment even when the mass itself is not causing symptoms.
Dysplastic nevi, for example, are atypical moles that sit on a biological continuum between ordinary moles and melanoma. They are considered intermediate both in appearance and in their underlying biology.19PubMed Central. Dysplastic nevi and melanoma While any single dysplastic nevus has a low chance of progressing to melanoma, having many of them increases overall skin cancer risk and prompts closer surveillance or preventive removal. Colon polyps are another classic example: most are benign, but certain types, particularly larger adenomatous polyps, carry enough transformation risk that they are routinely removed during colonoscopy.
Other benign tumors occasionally associated with malignant change include giant cell tumors of bone, certain ovarian tumors, and some types of salivary gland adenomas that have been present for many years. The risk varies widely by tumor type, and the likelihood of transformation is factored into treatment recommendations. If your doctor recommends removing a benign tumor you assumed was harmless, this kind of risk consideration is often the reason.
Recurrence After Treatment
One question people understandably have is whether a benign tumor will come back after treatment. The answer depends on the type of tumor and how it was removed.
Completely excised lipomas rarely recur. Fibroadenomas and benign phyllodes tumors of the breast also have low recurrence rates, and interestingly, margin status at surgery may matter less than you would think. A study of benign and low-grade breast fibroepithelial tumors found no significant difference in recurrence between patients with positive margins and those with clean margins, suggesting that conservative follow-up rather than re-excision is reasonable for many of these patients.20PubMed. Benign and low-grade fibroepithelial neoplasms of the breast have low recurrence rate after positive surgical margins
Meningiomas are at the other end of the spectrum. Even with successful treatment, they have a meaningful recurrence rate over a long follow-up period, which is why years of periodic imaging are standard after surgery or radiosurgery. Desmoid tumors, while benign, are locally aggressive and have a reputation for coming back, sometimes requiring multiple rounds of treatment. The pattern varies enough by tumor type that recurrence risk is best discussed with the treating physician in the context of your specific diagnosis.
The Psychological Weight of a “Benign” Diagnosis
Hearing that a growth is benign is supposed to be good news, and it is. But the emotional experience of living with a known tumor, even a harmless one, is more complicated than the word “benign” suggests. People told about an incidental brain finding on MRI, for instance, often experience real anxiety about the situation, from the shock of the initial news through the waiting period before a specialist consultation.21PubMed Central. Patients’ anxiety around incidental brain tumors: a qualitative study
This anxiety can influence treatment decisions. Some people opt for surgical removal of a tumor that could safely be watched simply because they cannot tolerate the uncertainty of surveillance. That is a legitimate reason to pursue treatment, as long as you understand the risks of the procedure and are not being driven purely by fear. If you find yourself in that position, asking your doctor to walk you through the natural history of the specific tumor type, meaning what it is realistically expected to do over the next five or ten years, can help calibrate whether intervention is worth the trade-offs.
Treating Benign Tumors in Children
Pediatric benign tumors deserve separate mention because children are not simply small adults when it comes to tumor treatment. The stakes of intervention are different in a growing body, particularly for brain tumors where treatment effects can ripple forward across decades of development.
Growth hormone deficiency is the most common long-term hormonal problem after treatment for pediatric brain tumors, whether the deficiency comes from the tumor’s location near the pituitary gland or from radiation and other treatment effects on that area. Other hormone deficiencies affecting growth, bone health, sexual development, and body composition can also follow.22PubMed Central. Pediatric brain tumor treatment: growth consequences and their management These consequences make the calculus of treatment different for a child: a small, slow-growing benign tumor that would be easy to justify watching in a 60-year-old adult may be treated earlier in a child to avoid the need for more aggressive intervention later, or it may be watched longer precisely because the side effects of treatment carry more developmental weight.
Neurological effects after surgery for childhood brain tumors are also worth understanding. Balance problems and cranial nerve issues are among the more common findings on long-term follow-up, and some of these are caused by the surgery itself rather than by the original tumor. Visual disturbances, including some cases of blindness, have been reported as surgery-related complications. The overall picture suggests that while surgery can be curative, it is not without lasting trade-offs for pediatric patients, and the decision to operate is made with those long-term consequences weighed carefully against the risks of leaving the tumor in place.